Pfizer Warns of Risks From Its Painkiller
688625
Pfizer warned doctors yesterday that one of its best-selling painkillers, Bextra, might increase the risk of heart attack or stroke in coronary artery bypass surgery patients.
373190
Pfizer Inc. on Friday said its popular Celebrex arthritis drug more than doubled the risk of heart attack in a large cancer-prevention trial, a setback that comes just weeks after Merck & Co. recalled its similar Vioxx drug due to heart safety risks.
730264
U.S. health regulators warned on  Monday of heart risks connected to over-the-counter painkiller  naproxen, a further blow to patients seeking pain relief that  creates additional confusion over the safety of similar drugs  after recent warnings for two other painkillers.
272511
Another blockbuster painkiller, Celebrex, has been found to raise the risk of heart attacks when taken in high doses, the drug&#39;s maker said yesterday.
157889
Description: Pfizer will stop advertising the painkiller Celebrex after discussions with the Food and Drug Administration. A study linked Celebrex to an increased risk of heart problems, but the company plans to keep it on the market.
57054
Pfizer Inc., the world&#39;s biggest drugmaker, said it will stop advertising its Celebrex painkiller to consumers after a study showed the drug more than doubled the risk of heart attacks when given in high doses.
75548
An anti-smoking drug sold by Pfizer Inc will carry more prominent warnings that patients be monitored for unusual activity including agitation, depression and suicidal behavior, the company said on Friday.
577633
The safety of Celebrex and other pain relievers was questioned Wednesday as scientists in the United States and regulatory agencies in Europe said they feared such drugs might raise the same risk of heart problems as those blamed on the arthritis medicine Vioxx.
98895
Drugmaker Pfizer announced Friday that its painkiller Celebrex puts patients at &quot;increased cardiovascular risk&quot; for heart problems, citing a long-term cancer study.
231780
GAITHERSBURG, Md.  - Rival drug giants Pfizer Inc.  PFE.N and Merck & Co. Inc. MRK.N argued conflicting views  of the dangers of their pain relievers on Wednesday to U.S.  science advisers weighing the risks of medicines similar to  recalled arthritis drug Vioxx.
478882
Pfizer (PFE) said Friday that is has received new information about the cardiovascular safety of its popular arthritis drug Celebrex, based on an analysis of a long-term cancer trial.
224987
Doctors should limit use of Pfizer Inc.&#39;s Celebrex and Bextra pain drugs while regulators continue to weigh their cardiovascular risks, the US Food and Drug Administration said.
665144
More evidence of how painkillers called COX-2 inhibitors can raise the risk of heart disease was published Monday, showing Pfizer Inc.'s Bextra can triple the risk of heart attack and stroke in certain patients.
214766
Doctors should limit use of Pfizer Inc.&#39;s Celebrex and Bextra pain drugs while regulators continue to weigh their cardiovascular risks, the US Food and Drug Administration said today.
675856
Pharmaceutical giant Pfizer Inc. has acknowledged that a 1999 study found Alzheimer's patients taking the pain killer Celebrex were up to four times more likely to have cardiovascular risk factors than those taking a placebo.
177569
The nation&#39;s top arthritis painkiller, Celebrex, raises the risk of major heart problems when taken at high doses, the drug&#39;s maker said Friday.
352014
Pfizer Inc. will warn doctors that its Bextra painkiller, which is in the same group of drugs as Merck &amp; Co.&#39;s withdrawn Vioxx, is linked to an elevated risk of blood clots, heart attacks and strokes in cardiac-surgery patients.